Exim SEO Articles

Cosmeceutical Export Secrets: How Indian Startups Can Save Registration Costs Legally

How to Reduce Cosmetic Product Registration Costs Legally: The Cosmeceutical Strategy Every Indian Merchant Exporter Must Understand

Can an Indian startup save lakhs of rupees in international product registration expenses by launching a skincare product instead of a pharmaceutical medicine?

This is an important question for entrepreneurs planning to start a pharmaceutical, cosmetic or personal-care export business without owning a manufacturing factory.

Many new merchant exporters search for products with strong demand, attractive selling prices and relatively low investment requirements.

Skincare products often attract their attention because they can be sourced from Indian manufacturers, supplied under private labels and sold through different international distribution channels.

However, one of the biggest mistakes entrepreneurs make is assuming that a pharmaceutical cream can become a cosmetic simply by changing its brand name, packaging or marketing description.

Imagine that a company manufactures a cream containing 1% hydrocortisone, a corticosteroid used in certain inflammatory skin conditions.

The company originally presents it as a medicine for itching, eczema and dermatitis.

Now suppose a trader changes the packaging, adds promotional emphasis on aloe vera and vitamin C, and starts calling the same formulation an advanced skin comfort cream.

Can this change eliminate pharmaceutical registration requirements?

No.

The medicine does not automatically become a cosmetic merely because its packaging looks like a beauty product.

Regulatory authorities examine the product's actual ingredients, intended use, claims and other characteristics.

This distinction is extremely important because incorrect product classification can lead to rejected shipments, recalls, financial losses and serious safety problems.

However, there is a genuine business opportunity behind the broader idea.

A startup can sometimes reduce market-entry costs by selecting an appropriate cosmetic product from the beginning rather than developing a regulated medicinal product.

The key is to make a legitimate product and regulatory decision, not to disguise a medicine.

Let us understand this opportunity through the example of hydrocortisone cream, the meaning of cosmeceuticals and the practical steps Indian merchant exporters should follow.

  1. Why Registration Costs Matter for Startup Merchant Exporters

Starting a pharmaceutical export business involves more than purchasing products from an Indian manufacturer.

The exporter must examine the importing country's regulatory requirements.

For some medicines, market entry may involve product registration, manufacturing documentation, quality data, stability information and other technical requirements.

Depending on the product and destination, additional scientific evidence or regulatory evaluation may be necessary.

These activities can create considerable expenses.

A manufacturer with an established regulatory department may already have the required expertise and documentation.

A startup merchant exporter may not.

This difference can make certain pharmaceutical projects financially difficult for beginners.

For example, imagine that an entrepreneur has limited capital available for product development and international marketing.

If a substantial part of that money must be committed to registration before the first commercial sale, the business may experience financial pressure.

The entrepreneur may still consider the opportunity, but only after studying the expected demand, registration costs, manufacturing readiness and commercial risks.

A more manageable approach may involve selecting a product category with a different regulatory pathway.

This is where cosmetic skincare products become worth investigating.

However, lower regulatory complexity does not mean zero compliance.

Every destination market has its own rules.

  1. Understanding the Difference Between a Medicine and a Cosmetic

Before starting any skincare export business, entrepreneurs should understand two basic product categories.

A pharmaceutical medicine is generally intended to diagnose, treat, prevent or relieve a medical condition, or otherwise produce a legally relevant therapeutic effect.

A cosmetic is generally intended for purposes such as cleansing, beautifying, improving appearance or maintaining the skin in an appropriate cosmetic condition.

Consider two different products.

Product A is a moisturizing cream intended to help the skin feel soft and reduce ordinary dryness.

Product B is a hydrocortisone cream intended to relieve inflammation and itching associated with certain medical conditions.

Although both are applied to the skin, they have different intended functions.

They may therefore fall under different regulatory requirements.

This distinction is important for international exporters.

A product does not become a cosmetic simply because it is presented in an attractive tube or promoted as a premium skincare solution.

Its composition, function, claims and regulatory status must be evaluated.

  1. What Is a Cosmeceutical?

The word cosmeceutical is commonly used in the skincare industry.

It combines two terms:

Cosmetic.

Pharmaceutical.

Businesses often use the word to describe skincare products that contain ingredients associated with advanced skin science or enhanced cosmetic performance.

For example, a company may market a moisturizing cream containing suitable botanical extracts, vitamins or other skincare ingredients as a cosmeceutical product.

However, an important legal distinction must be understood.

Cosmeceutical is not a universal regulatory category.

In the United States, the Food and Drug Administration explicitly states that the term cosmeceutical has no legal meaning under the Federal Food, Drug, and Cosmetic Act.

A product can be classified as a cosmetic, a drug or both, depending on the applicable requirements.

Using the word cosmeceutical does not automatically create a special exemption from drug regulation.

Other countries may also apply their own product classification rules.

Therefore, Indian exporters should never assume that the term cosmeceutical automatically provides a cheaper registration pathway.

The correct classification must be determined for the exact formulation and destination country.

  1. Understanding the Hydrocortisone Cream Example

Let us examine the product discussed in the video.

Hydrocortisone is a corticosteroid medicine.

Topical hydrocortisone preparations are used in certain circumstances to relieve inflammation and itching associated with skin conditions.

Examples may include selected forms of eczema, dermatitis and other inflammatory skin problems, depending on the product's authorized indications.

The video discusses a cream containing approximately 1% hydrocortisone.

This is a recognized concentration found in certain medicinal creams.

However, the legal status of hydrocortisone products differs between markets.

For example, some 1% hydrocortisone products in the United States are marketed as over-the-counter medicines under applicable requirements.

That does not make them cosmetics.

In other countries, hydrocortisone products may be subject to different prescription, pharmacy or registration rules.

Therefore, a merchant exporter must not assume that the same product can be supplied under identical conditions worldwide.

The exporter must verify the country-specific requirements before planning commercial supply.

  1. Why Hydrocortisone Is Not an Ordinary Cosmetic Ingredient

Hydrocortisone is not simply a moisturizing ingredient.

It has pharmacological activity.

As a corticosteroid, it can reduce certain inflammatory responses.

This is why it is used in appropriate medical treatments.

However, the product also requires proper precautions.

Topical corticosteroids can cause adverse effects, particularly when used improperly, over prolonged periods or under unsuitable conditions.

Potential problems may include skin thinning and other local reactions.

Therefore, it is important that products containing hydrocortisone are accurately identified and supplied with appropriate information.

If a cream contains hydrocortisone but the label deliberately hides the ingredient, the customer may not realize that a medicinal corticosteroid is being applied.

This can create health and regulatory risks.

A startup should never treat an undisclosed drug ingredient as a harmless marketing detail.

  1. The Dangerous Mistake: Hiding Hydrocortisone Behind Cosmetic Ingredients

Now imagine two presentations of the same hypothetical cream.

The first presentation identifies the product as a hydrocortisone medicinal cream.

The second presentation calls it an advanced skin comfort cream and prominently features aloe vera and vitamin C.

However, the second cream still contains the same 1% hydrocortisone.

If the company deliberately conceals the corticosteroid and presents the product as an ordinary cosmetic to avoid drug requirements, the change is not a legitimate regulatory strategy.

The product's real composition remains important.

Aloe vera, vitamin C, attractive packaging and cosmetic-style advertising cannot erase the presence of a pharmacologically active corticosteroid.

A product containing both cosmetic and medicinal components may also be subject to drug-related requirements.

For example, the US FDA recognizes that some products can be both drugs and cosmetics.

Such products must satisfy the applicable requirements for their classifications.

Therefore, changing the visible marketing emphasis does not automatically eliminate the medicinal product's obligations.

The proper strategy is to classify the actual product correctly.

  1. Why the Word Active Ingredient Matters

The video discusses presenting aloe vera and vitamin C as the active ingredients while not highlighting hydrocortisone.

This raises another important technical issue.

In pharmaceutical regulation, an active drug ingredient is a substance responsible for the intended pharmacological activity of the medicine.

In ordinary skincare advertising, companies sometimes use the word active more broadly to describe prominent or functional cosmetic ingredients.

These meanings are not interchangeable.

A business cannot simply choose which ingredients it wants regulators to consider active.

For example, if hydrocortisone is included to provide an anti-inflammatory medicinal effect, emphasizing aloe vera on the front label does not remove the hydrocortisone's drug-related significance.

Product composition and the applicable legal definitions determine what information must be disclosed and how the product is regulated.

For startup merchant exporters, this is a critical lesson.

A marketing claim does not override the product's technical reality.

  1. Why the European Union Is Especially Important in This Example

The European Union provides a clear example of why the proposed rebranding strategy is unsuitable.

Regulation (EC) No 1223/2009 governs cosmetic products placed on the EU market.

Its Annex II lists substances prohibited in cosmetic products.

Entry 300 covers glucocorticoids, also called corticosteroids.

Hydrocortisone belongs to this pharmacological family.

Therefore, a hydrocortisone-containing cream cannot simply be marketed as an ordinary EU cosmetic by changing its name or adding other skincare ingredients.

A business seeking to supply a genuine medicinal hydrocortisone product must instead examine the applicable pharmaceutical requirements.

For Indian exporters, this demonstrates a fundamental principle.

Before developing a product for international markets, verify whether its ingredients are permitted within the intended legal category.

Do not complete the product formulation first and investigate classification only after the packaging has been printed.

  1. A Real Example of the Risks of Undisclosed Steroids

Regulatory authorities have taken action against skincare products containing inappropriate or undisclosed corticosteroids.

For example, in 2024 the United Kingdom's Office for Product Safety and Standards published a safety report concerning a steroid-containing cream originating from India.

Testing identified betamethasone dipropionate, a corticosteroid prohibited in cosmetic products under the applicable rules.

The regulatory response included destruction of the product.

This case involved a different corticosteroid, not the specific hydrocortisone formulation discussed here.

Nevertheless, it illustrates the commercial and safety risks of supplying steroid-containing creams as cosmetics.

A shipment may be rejected or destroyed.

The importer may face regulatory difficulties.

The exporter may lose money and business relationships.

The brand's reputation may also suffer.

Therefore, a shortcut that appears to save registration expenses can ultimately create much larger losses.

  1. The Genuine Opportunity: Develop a Real Cosmetic Product

Now let us examine how the underlying business idea can be used correctly.

Suppose an Indian entrepreneur wants to enter the international skincare market.

The original idea is to offer a product for people interested in everyday skin comfort.

Instead of manufacturing a hydrocortisone medicine and hiding the drug ingredient, the entrepreneur can work with a qualified cosmetic manufacturer to develop a genuine cosmetic formulation.

For example, the product might be a moisturizing cream containing permitted skincare ingredients.

Depending on formulation suitability, these may include aloe vera, glycerin, appropriate emollients or suitable vitamin-derived cosmetic ingredients.

However, their use must be supported by safety and formulation evaluation.

The product should be designed for an appropriate cosmetic purpose.

For example, it may be intended to moisturize dry skin or improve the feeling of skin softness.

It should not claim to cure eczema, treat dermatitis or suppress disease-related inflammation unless it follows an applicable authorized medicinal pathway.

This creates a genuinely different product.

The change is not merely in advertising.

The actual formulation, intended use and regulatory position are different.

That is the proper foundation for a cosmetic export strategy.

  1. What Can a Cosmetic Skin Comfort Cream Legitimately Claim?

Cosmetic claims must be accurate, supportable and appropriate for the target country.

For example, depending on the product and available evidence, a cosmetic moisturizer may be able to make claims such as:

Helps moisturize dry skin.

Leaves the skin feeling soft.

Helps reduce the feeling of dryness.

Provides everyday skin comfort.

Supports the skin's cosmetic appearance.

These are illustrative examples, not automatic authorizations.

The actual claims must be reviewed against the formulation, supporting data and destination-market rules.

Now compare those statements with claims such as:

Treats eczema.

Cures dermatitis.

Stops allergic skin inflammation.

Provides medicinal relief from inflammatory skin disease.

These claims can indicate medicinal purposes and may change the product's legal classification.

For exporters, understanding this difference is essential.

The goal is not to disguise a therapeutic claim using softer language.

The goal is to market a genuinely cosmetic function supported by the product's actual properties.

  1. Can Aloe Vera and Vitamin C Create a Premium Skincare Product?

Aloe vera and vitamin C are commonly discussed in the skincare industry.

They may form part of suitable cosmetic formulations.

However, their presence does not automatically establish superior quality.

For example, aloe-derived ingredients can vary in composition and processing.

Vitamin C ingredients can differ in stability, chemical form and formulation requirements.

A cream containing these ingredients must still be evaluated for its intended purpose.

Important considerations may include ingredient quality, compatibility, stability, microbial safety and skin tolerance.

A product with a large advertised ingredient percentage is not automatically better than another product.

The finished formulation matters.

For merchant exporters, the opportunity is to develop an accurately specified, tested and appropriately marketed product.

Premium positioning should come from genuine quality and customer value, not from hiding medicinal ingredients.

  1. How Legitimate Product Selection Can Reduce Registration Expenses

There is a meaningful difference between avoiding unnecessary regulatory expenses and avoiding necessary regulation.

Avoiding unnecessary expenses means selecting a product category and business model that can be managed legally within your resources.

For example, suppose your startup has limited investment.

You compare two business ideas.

The first involves introducing a new medicinal skin cream into a highly regulated foreign market.

The second involves supplying a properly formulated cosmetic moisturizer through a qualified local distributor.

The medicinal route may require a pharmaceutical registration or authorization process, supported by the necessary technical data.

The cosmetic route may have a different regulatory framework involving product safety, formulation documentation, labelling and notification requirements.

Depending on the destination market, the second route may have lower market-entry complexity or cost.

However, this is not guaranteed.

Some cosmetics also involve substantial documentation, testing and local compliance costs.

The correct approach is to compare the actual costs of the two legitimate business models.

This is how entrepreneurs can make smarter investment decisions.

  1. Cosmetics Are Not Registration-Free Products

One common misconception is that cosmetics can be exported without regulatory checks.

This is incorrect.

Different countries impose different requirements.

For example, the European Union requires an appropriate Responsible Person for products placed on its cosmetic market.

The product must undergo a suitable safety assessment.

A Product Information File must be maintained.

Product notification through the Cosmetic Products Notification Portal is also required.

The product must comply with ingredient restrictions, labelling requirements and other applicable rules.

Therefore, although cosmetic products may follow a different pathway from prescription medicines, they are still regulated products.

The exporter must budget for the relevant requirements.

A successful strategy is based on understanding those obligations, not ignoring them.

  1. Cosmetic Export Regulations in India

India regulates cosmetics through the applicable provisions of the Drugs and Cosmetics Act and the Cosmetics Rules, 2020, including amendments.

Cosmetic manufacturing is regulated through the appropriate licensing framework.

A startup sourcing finished cosmetic products should verify that the Indian manufacturer holds the applicable authorization.

The product must also meet the relevant quality, safety and labelling requirements.

For entrepreneurs working through merchant-export arrangements, the business should be structured according to the actual roles of the manufacturer, marketer and exporter.

It is important to understand that rules governing the import of cosmetics into India are different from the requirements for exporting Indian-made cosmetics.

For example, a foreign cosmetic being imported into India may require a specific CDSCO import registration.

An Indian manufacturer exporting cosmetics must meet the applicable Indian manufacturing and export obligations together with the requirements of the destination market.

Startups should avoid confusing these two situations.

  1. Can Merchant Exporters Start Without Owning a Factory?

Yes.

A merchant exporter can source suitable products from qualified Indian manufacturers.

The entrepreneur does not necessarily need to establish a pharmaceutical or cosmetic manufacturing facility.

For example, a startup may approach a licensed Indian cosmetic manufacturer capable of producing moisturizing creams.

The manufacturer can discuss available formulations, minimum order quantities, packaging options and relevant quality documents.

The merchant exporter can then identify suitable international buyers.

Depending on the business arrangement, the exporter may coordinate product specifications, samples, packaging, export pricing and shipment.

However, the exporter must be clear about its actual role.

A merchant exporter should not claim to manufacture the product when it is produced by another company.

Private labelling or marketing under the exporter's brand may also create additional responsibilities, particularly in foreign markets.

These must be understood before launching the product.

  1. The Importance of Selecting the Right Manufacturer

Imagine that a manufacturer offers a very attractive price for a skincare cream.

The supplier says the product contains aloe vera and vitamin C.

However, the company provides very limited technical documentation.

A second manufacturer quotes a slightly higher price but provides relevant formulation specifications, quality reports and available stability information.

Which manufacturer should you select?

The answer should not be based on price alone.

A startup must evaluate whether the manufacturer can consistently supply a product that meets the buyer's requirements.

Important areas include manufacturing authorization, ingredient quality, formulation control, microbial testing, stability and packaging compatibility.

For a legitimate cosmetic product, the exporter may also request documentation relating to manufacturing practices.

ISO 22716 provides internationally recognized guidance on cosmetic Good Manufacturing Practices.

However, a certificate alone does not prove that every finished product meets all applicable legal requirements.

Supplier evaluation should be based on the complete product and manufacturing arrangement.

  1. Why Product Testing Is Essential

A skincare product may look attractive during initial sample evaluation.

But what happens after several months of storage?

Does the cream remain stable?

Does its colour change?

Does it separate into different layers?

Does the packaging remain compatible?

Can microbial contamination become a concern?

These are important practical questions.

Depending on the formulation, manufacturers may perform relevant stability testing, microbial quality testing and preservative efficacy evaluation.

ISO 11930 provides a framework for evaluating antimicrobial protection in certain cosmetic products.

For merchant exporters, suitable testing can help reduce the risk of buyer complaints and rejected shipments.

However, the testing programme must be established for the actual formulation.

A generic certificate cannot replace product-specific evaluation.

  1. The Real Business Difference Between a Drug Cream and a Cosmetic Cream

Let us return to the original case study.

Product A is a genuine hydrocortisone cream intended for an authorized medicinal application.

Product B is a genuine cosmetic moisturizer developed without undisclosed medicinal corticosteroids.

Both may be supplied in cream form.

Both may be manufactured in India.

Both may be sold through suitable international business partners.

However, their purposes and regulatory obligations differ.

Product A must follow the applicable pharmaceutical pathway.

Product B must follow the applicable cosmetic pathway.

The exporter should not describe Product B as providing the same treatment effect as Product A unless there is a separate lawful basis for that claim.

This is particularly important for skin conditions such as eczema and dermatitis.

A cosmetic moisturizer may form part of general skincare, but it is not automatically a replacement for medical treatment.

A startup should never promise equivalent therapeutic benefits merely because the cosmetic product is easier to register.

  1. How to Compare Registration Costs Before Selecting a Product

Startups should prepare a complete market-entry cost estimate.

For a medicinal product, possible costs may include regulatory documentation, registration-related fees, manufacturing compliance and market authorization activities.

For a cosmetic product, possible costs may include safety assessment, product documentation, testing, labelling, responsible-person services and required notifications.

The exact expenses differ by country and product.

Instead of assuming that cosmetics always cost less, request written estimates from qualified regulatory specialists or local business partners.

Ask which charges are mandatory.

Identify one-time expenses.

Identify recurring annual expenses.

Clarify who pays for product testing and safety documentation.

Determine whether packaging and formulation changes create additional costs.

Also consider the expected order volume.

A product with low registration costs may still be commercially unattractive if the buyer demand is weak.

A product with substantial regulatory costs may be commercially viable if there is a reliable market and an appropriate long-term supply agreement.

Therefore, the decision must consider both costs and potential revenue.

  1. A Practical Market-Entry Example for an Indian Startup

Imagine an entrepreneur who wants to launch a skincare product in an overseas market.

The entrepreneur has a limited budget and does not own a factory.

Initially, the entrepreneur considers hydrocortisone cream because there is demand for products used in skin conditions.

After researching the requirements, the entrepreneur learns that the medicine involves specific regulatory obligations.

The entrepreneur then evaluates a second, genuinely different business concept: a cosmetic moisturizer for everyday skin comfort.

A qualified manufacturer proposes an appropriate cosmetic formulation.

The entrepreneur obtains samples and relevant quality documentation.

Next, the entrepreneur identifies the target market's requirements.

The proposed product, ingredients and claims are reviewed for that market.

The entrepreneur then works with a suitable importer or local responsible party, where required.

After the necessary compliance arrangements are completed, the exporter can begin the agreed commercial supply.

This example demonstrates how startups can reduce complexity through legitimate product selection.

It does not involve hiding hydrocortisone or pretending that the original medicine has become a cosmetic.

  1. Which International Buyers Should Cosmetic Merchant Exporters Target?

The right buyer depends on the product and market.

For a genuine cosmetic moisturizer, potential customers may include:

Cosmetic product importers.

Skincare distributors.

Private-label beauty brands.

Personal-care wholesalers.

Authorized cosmetic retailers.

Relevant e-commerce sellers.

Specialized skincare distribution companies.

However, each buyer category may have different requirements.

For example, a private-label brand may want customized packaging and product specifications.

An importer may be more concerned about documentation, labelling and local regulatory compliance.

A retailer may focus on product positioning, shelf life, packaging and consumer demand.

Therefore, the exporter should identify the correct buyer before finalizing the product.

  1. Why Importers May Prefer a Well-Prepared Merchant Exporter

A foreign importer may already have several Indian manufacturers to choose from.

Why should the buyer work with a merchant exporter?

The answer depends on the services the exporter provides.

For example, a knowledgeable merchant exporter may help the buyer compare manufacturers, coordinate samples, verify available documentation and manage production requirements.

The exporter may also help coordinate packaging and shipment through suitable partners.

If the buyer needs several related skincare products, the merchant exporter may coordinate sourcing from more than one qualified manufacturer.

However, this model works only when the exporter creates genuine value.

Simply adding a margin to a manufacturer's catalogue does not automatically justify the business relationship.

Technical understanding, transparency and reliable execution are important.

  1. Why Private Labelling Requires Special Attention

Private labelling can be attractive to startups because a manufacturer may produce a finished skincare product under another company's brand.

However, the exporter should examine the legal responsibilities involved.

For example, in some markets, the company placing the product under its own name may assume important compliance obligations.

The importer or local responsible person may also have defined duties.

The parties should agree on who controls the formula, packaging information, product documentation and regulatory records.

They should also define responsibilities for quality complaints, recalls and other potential problems.

A merchant exporter should not assume that all liability remains with the manufacturer.

The commercial agreement must reflect the actual product and destination-country requirements.

  1. Can Startups Reduce Costs Through Existing Cosmetic Formulations?

One possible business approach is to work with a manufacturer that already produces a suitable and well-documented cosmetic formulation.

For example, the manufacturer may have an established moisturizing cream with available quality and stability information.

Instead of requesting a completely new formula, the entrepreneur can investigate whether that product meets the target buyer's requirements.

This may reduce certain product-development expenses.

However, an existing formulation does not automatically eliminate destination-country compliance requirements.

New packaging, branding, ingredient changes or market-specific claims may still require additional evaluation.

The exporter should also verify the contractual right to use the manufacturer's existing formulation under the proposed brand.

This approach can be useful for startups seeking to control initial investment.

  1. Can a Local Importer Help Share Market-Entry Costs?

Yes, some international buyers may be willing to share certain costs when they see a genuine commercial opportunity.

For example, a foreign skincare distributor may want a private-label product from India.

The distributor may agree to handle some local compliance activities under the commercial arrangement.

The Indian manufacturer may provide necessary technical documentation.

The merchant exporter may coordinate sourcing and international supply.

However, cost sharing is a commercial negotiation.

It is not automatic.

The importer may request exclusive distribution rights, suitable prices or minimum order quantities in exchange for its investment.

Before agreeing, the parties should clarify financial responsibilities, regulatory roles and what happens if the business relationship ends.

This can help protect the startup from unexpected expenses.

  1. How to Calculate Real Profitability

A cosmetic product may appear profitable when the Indian manufacturing price is compared with the overseas retail price.

However, the retail price is not the merchant exporter's profit.

The complete business cost may include product procurement, packaging, testing, documentation, inland transport, freight, banking charges and other expenses.

Depending on the agreed arrangement, market-entry compliance costs may also be relevant.

The local distributor may incur import duties, taxes, warehousing, marketing and retail distribution expenses.

A private-label launch may require design, packaging development and additional sample approvals.

Therefore, startups should calculate profitability according to the actual transaction.

A low manufacturing price is useful only when the final product meets the legal, technical and commercial requirements.

The goal is not simply to save registration fees.

The goal is to build a profitable business after accounting for all legitimate costs.

  1. Why Registration Cost Is Only One Part of the Business Decision

Imagine that Product A requires more regulatory investment but has a qualified buyer prepared to place repeat orders after authorization.

Product B requires less regulatory investment but has no confirmed customer interest.

Which opportunity is better?

The answer cannot be determined from registration costs alone.

The entrepreneur must examine expected sales, market competition, product quality, available partners and the investment required.

Sometimes the lower-compliance product may be more attractive.

In other situations, a regulated pharmaceutical product supplied through an established partner may offer stronger commercial potential.

Therefore, startups should not always avoid regulated products.

Instead, they should select the business model that best matches their capital, knowledge and market access.

  1. How to Avoid Misleading Product Claims

A product's label and advertising should accurately communicate its real nature.

Do not call a medicine a cosmetic merely to reduce registration expenses.

Do not hide pharmacologically active ingredients.

Do not claim that a moisturizer cures eczema unless the product has the required authorization for that intended use.

Do not assume that aloe vera, vitamin C or other cosmetic ingredients cancel out the regulatory significance of a drug ingredient.

Do not rely solely on a manufacturer's verbal claim that a product is registration-free.

Before entering a market, obtain suitable written classification guidance from a qualified regulatory professional or the competent authority when necessary.

The business should be built around legitimate compliance decisions.

This protects both customers and the exporter's long-term reputation.

  1. A Step-by-Step Roadmap for Indian Merchant Exporters

Step 1: Identify the Customer Need

Decide whether the market requires a therapeutic medicine or a cosmetic skincare product.

Step 2: Define the Intended Product

Clarify what the product is supposed to do.

Step 3: Verify Regulatory Classification

Check whether the formulation and claims place the product under medicinal, cosmetic or another applicable requirements framework.

Step 4: Select the Target Country

Research its ingredient restrictions, registration, notification and import requirements.

Step 5: Evaluate Qualified Indian Manufacturers

Request appropriate manufacturing licences, product specifications and available quality documentation.

Step 6: Examine the Complete Formula

Verify the relevant ingredients and confirm that no undisclosed medicinal substances are present.

Step 7: Develop Appropriate Claims

Prepare cosmetic or medicinal claims according to the product's legitimate classification and available evidence.

Step 8: Evaluate Product Samples

Assess relevant quality, stability and packaging characteristics.

Step 9: Estimate Compliance Costs

Request suitable quotations for mandatory regulatory and technical activities.

Step 10: Identify Suitable International Buyers

Approach importers or distributors whose business matches the product category.

Step 11: Clarify Local Responsibilities

Determine whether the buyer, importer or another authorized party will perform the relevant local compliance role.

Step 12: Prepare Complete Export Costing

Include manufacturing, testing, packaging, logistics and agreed regulatory expenses.

Step 13: Finalize Commercial Agreements

Clarify payment terms, brand rights, quality responsibilities, minimum orders and commercial commitments.

Step 14: Complete Required Compliance

Ensure that the product satisfies the relevant rules before commercial placement in the destination market.

Step 15: Build Repeat Business

Focus on consistent quality, genuine consumer value and dependable supply.

This process provides a practical foundation for startup entrepreneurs without encouraging shortcuts around pharmaceutical regulation.

  1. A Practical Supplier Questionnaire

When approaching an Indian manufacturer for a skincare export project, ask the following questions:

Is the product legally classified as a cosmetic or medicine?

What is its exact intended use?

Can you provide a complete relevant ingredient declaration?

Does the formula contain hydrocortisone or any other medicinal corticosteroid?

Which cosmetic manufacturing authorizations do you hold?

What quality standards do you follow?

What testing has been completed?

Are stability and microbial quality reports available?

Can the product support the proposed label claims?

Have you supplied this product to the intended export market before?

What packaging and private-label options are available?

What minimum order quantity is required?

Can you provide market-specific documentation?

Will the formula remain consistent between production batches?

What commercial and quality responsibilities will be covered in the agreement?

These questions help the exporter evaluate whether the proposed product is genuinely suitable for international business.

  1. The Bigger Business Lesson: Smart Exporting Is Not About Hiding Information

Many entrepreneurs want to reduce investment because their available capital is limited.

This is a reasonable business objective.

However, saving money should not depend on misleading buyers or regulatory authorities.

For example, concealing a corticosteroid may seem like a shortcut.

But it introduces risks that can damage the entire business.

A better strategy is to reduce unnecessary costs through proper planning.

Choose a suitable product.

Use qualified manufacturers.

Understand the destination market.

Avoid unsupported claims.

Work with reliable importers.

Prepare the correct documentation.

And negotiate expenses before making large commitments.

These activities may not sound as exciting as discovering a secret registration loophole.

But they provide a stronger foundation for long-term international business.

  1. Why Product Knowledge Can Create a Competitive Advantage

A new merchant exporter may not have a factory, a famous brand or a large marketing budget.

However, the entrepreneur can still develop useful expertise.

For example, understanding the difference between a corticosteroid medicine and a moisturizing cosmetic can prevent a serious business mistake.

Knowing the purpose of a safety assessment can improve supplier discussions.

Understanding the requirements of an overseas importer can help prepare more relevant quotations.

Learning about ingredient specifications can reduce the risk of purchasing an unsuitable product.

These skills are valuable because international business involves making informed decisions before investing money.

An exporter who understands the product can communicate more professionally with both manufacturers and buyers.

This is especially important in healthcare and skincare sectors, where product claims can affect consumer safety.

  1. Final Thoughts: How Indian Startups Can Save Registration Costs Responsibly

The hydrocortisone cream example highlights one of the most important lessons in pharmaceutical and cosmetic exporting.

A medicinal cream cannot automatically become a cosmetic simply because the company changes its packaging, emphasizes aloe vera or vitamin C, or describes it as an advanced skin comfort cream.

If the product still contains a medicinal corticosteroid, the actual formulation and applicable legal requirements remain important.

The term cosmeceutical is not a universal legal category that allows exporters to bypass pharmaceutical regulation.

However, entrepreneurs can legitimately explore the cosmetic industry as a separate business opportunity.

A suitable cosmetic moisturizer may have different regulatory requirements from a medicinal hydrocortisone cream.

This can sometimes make the market-entry project more manageable for a startup.

The important distinction is that the cosmetic must be a genuinely appropriate product, with permitted ingredients, truthful claims and the necessary compliance arrangements.

For Indian merchant exporters with limited capital, the correct strategy is to compare complete business models before selecting a product.

Do not choose a regulated medicine merely because it appears highly profitable.

Do not select a cosmetic simply because somebody promises that registration is unnecessary.

Study the product.

Understand the legal classification.

Verify the manufacturer.

Calculate the complete costs.

Identify genuine buyer demand.

And select a market-entry strategy that your business can manage responsibly.

Remember one important business principle:

The smartest exporter is not the person who hides a product's real nature to avoid regulations. The smartest exporter is the person who selects the right product and market from the beginning, so that unnecessary costs are avoided without compromising safety or compliance.

At Barai Overseas, we focus on helping Indian entrepreneurs understand pharmaceutical and cosmetic product selection, manufacturer sourcing, international market requirements, business development and practical merchant-export strategies.

Our objective is to help startups build sustainable export businesses based on knowledge, reliable sourcing and responsible commercial decisions.

Watch Our Original Video

How to Save Lakhs on Registration – The Cosmeceutical Secret

https://www.youtube.com/watch?v=YYbYuEMUWsI

For more practical export-import business learning resources, visit:

https://www.exportimport.guru/

Useful Official and Technical References

  1. US FDA – What Is a Cosmeceutical?

https://www.fda.gov/cosmetics/cosmetics-labeling-claims/cosmeceutical

  1. US FDA – Is a Product a Cosmetic, a Drug or Both?

https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap

  1. US FDA – Cosmetics Labelling Guide

https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide

  1. US National Library of Medicine – Hydrocortisone 1% Drug Labelling

https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9bb98452-a605-5c20-e053-2995a90a1ea7

  1. European Union – Regulation (EC) No 1223/2009 on Cosmetic Products

https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32009R1223

  1. European Commission – Cosmetics Legislation

https://single-market-economy.ec.europa.eu/sectors/cosmetics/legislation_en

  1. European Commission – Cosmetic Products Notification Portal

https://single-market-economy.ec.europa.eu/sectors/cosmetics/cosmetic-product-notification-portal_en

  1. CDSCO – Cosmetic Regulations in India

https://www.cdsco.gov.in/opencms/opencms/en/Cosmetics/cosmetics/

  1. CDSCO – Cosmetics Rules, 2020

https://www.cdsco.gov.in/opencms/en/Acts-and-rules/Cosmetics-Rules/

  1. US FDA – Warning About a Product Containing an Undisclosed Steroid

https://www.fda.gov/drugs/drug-safety-and-availability/do-not-purchase-or-use-skin-cap-aerosol-spray-products-because-they-may-be-harmful-your-health

  1. UK Government – Safety Report Concerning a Steroid-Containing Cream

https://www.gov.uk/product-safety-alerts-reports-recalls/product-safety-report-pts-packers-and-providers-pvt-surfaz-sn-triple-action-cream-2312-0059

  1. Directorate General of Foreign Trade, India

https://www.dgft.gov.in/

Hare Krishna.

Barai Overseas – Export Import Guru

Tags: Cosmeceutical Export Secrets: How Indian Startups Can Save Registration Costs Legally